Pen Needles Market Report 2026

Pen Needles Market Overview

• Pen Needles market size has reached to $2.69 billion in 2025 • Expected to grow to $4.34 billion in 2030 at a compound annual growth rate (CAGR) of 9.7% • Growth Driver: Increasing Prevalence Of Diabetes Fuels Growth In The Pen Needles Market • Market Trend: Innovative Multi-Bevel Needle Technology Enhances Comfort And Accessibility • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pen Needles Market?

Pen needles refer to small, disposable devices used to administer insulin via insulin pens, designed for subcutaneous injection. They feature a thin, sharp needle for minimal discomfort and are available in various lengths and gauges to accommodate different patient needs and preferences. These needles are important in managing diabetes by facilitating convenient and precise insulin delivery. The main types of pen needles are standard pen needles and safety pen needles. Standard pen needles are medical devices used for the subcutaneous injection of medication, primarily insulin, by individuals with diabetes. These needles come in various lengths, such as short-length pen needles, medium-length pen needles, and long-length pen needles, and are used in various therapies, including insulin, glucagon-like-peptide-1 (GLP-1), and growth hormone. These can be purchased in retail and non-retail settings and utilized by various end-users, such as hospitals and clinics, home healthcare, and others.

What Is The Pen Needles Market Growth Forecast?

The pen needles market size is expected to see strong growth in the next few years. It will grow to $4.34 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to increasing adoption of GLP-1 therapies, rising focus on needle safety regulations, expansion of sustainable disposable medical products, growing demand for painless injection solutions, increasing preference for home-based disease management. Major trends in the forecast period include increasing adoption of ultra-thin pen needles, rising demand for safety pen needle solutions, growing preference for short-length needles, expansion of home-based injection therapies, enhanced focus on patient comfort and compliance.

Global Pen Needles Market Segmentation

1) By Type: Standard Pen Needles, Safety Pen Needles 2) By Needle Length: Short Length Pen Needles, Medium Length Pen Needles, Long Length Pen Needles 3) By Therapy: Insulin, Glucagon-like-Peptide-1 (GLP-1), Growth Hormone 4) By Mode Of Purchase: Retail, Non-Retail 5) By End User: Hospitals And Clinics, Home Healthcare, Other End Users Subsegments: 1) By Standard Pen Needles: Fixed-Needle Pen Needles, Removable-Needle Pen Needles, Short Pen Needles ( 4mm, 5mm), Long Pen Needles ( 8mm, 12mm) 2) By Safety Pen Needles: Automatic Safety Pen Needles, Manual Safety Pen Needles, Retractable Safety Pen Needles, Shielded Safety Pen Needles

What Is The Driver Of The Pen Needles Market?

The increasing prevalence of diabetes is expected to propel the growth of the pen needles market going forward. Diabetes presents as a persistent health issue marked by high blood sugar levels, stemming from inadequate insulin production or the body's ineffective utilization of insulin. The increasing prevalence of diabetes can be attributed to factors such as sedentary lifestyles, unhealthy dietary habits, genetic predisposition, urbanization, and aging populations, compounded by limited access to healthcare and rising obesity rates worldwide. Pen needles are indispensable tools for diabetes management, enabling precise insulin delivery through convenient, minimally invasive injections, promoting better glycemic control, and enhancing patient compliance. For instance, in June 2024, according to the National Health Service, a UK-based government department, in 2023, the NHS identified over half a million (549,000) additional individuals in England at risk of developing type 2 diabetes, bringing the total number of people with non-diabetic hyperglycemia, or pre-diabetes, registered with a GP to 3,615,330. This represents a significant increase compared to 3,065,825 in 2022, highlighting a rise of nearly 20%. Therefore, the increasing prevalence of diabetes is driving the growth of the pen needles industry.

Key Players In The Global Pen Needles Market

Major companies operating in the pen needles market are Cardinal Health Inc., Novo Nordisk AS, Becton Dickinson And Company, B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, Artsana Group, Embecta Corp., Trividia Health Inc., Medical Technology And Devices S.p.A., Owen Mumford, Dynarex Corporation, UltiMed Inc., Bio-Med HealthCare Products Pvt. Ltd., Allison Medical Inc., GlucoRx Ltd., HTL-STREFA S.A., Hindustan Syringes And Medical Devices Ltd., Ypsomed AG, Haselmeier GmbH

Global Pen Needles Market Trends and Insights

Major companies operating in the insulin pen-needle market are focusing on developing innovative solutions, such as advanced multi-bevel needles, to enhance injection comfort and improve patient compliance. Advanced multi-bevel needles are insulin pen needles designed with multiple precision-cut bevels at the tip to make injections smoother, less painful, and more comfortable for patients. For instance, in August 2025, Trividia Health Inc., a US-based diabetes-care company, launched its TRUEplus 5-Bevel Pen Needles in the UK. These pen needles are available in multiple gauges and lengths (e.g., 31 G 5 mm, 6 mm, 8 mm; and 32 G 4 mm), have a silicone coating for reduced friction, have a sterile single-use construction, and have color-coded caps for easy size recognition—all aimed at maximizing comfort, safety, and ease of use. Moreover, they are the lowest-priced 5-bevel pen needles offered on prescription in the UK, making them a cost-effective yet high-quality alternative to older 3-bevel designs.

What Are Latest Mergers And Acquisitions In The Pen Needles Market?

In August 2024, Medical Technology and Devices S.p.A. (MTD), an Italy-based medical device manufacturer acquried of Ypsomed’s pen-needle and blood-glucose-monitoring (BGM) business. With this acquisition, MTD expands its total pen-needle production capacity to over 2.5 billion units, reinforcing its position as a leading global provider of pen needles. Ypsomed Holding AG is a Switzerland-based diabetes care technology company known for its portfolio of injection and monitoring solutions.

Regional Outlook

North America was the largest region in the pen needles market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Pen Needles Market?

The pen needles market consists of sales of painless pen needles, adjustable pen needles, reusable pen needles, and fixed-dose pen needles. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.